ProShare Advisors LLC Takes $110,000 Position in Enhabit, Inc. (NYSE:EHAB)

ProShare Advisors LLC purchased a new position in Enhabit, Inc. (NYSE:EHAB) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 14,023 shares of the company’s stock, valued at approximately $110,000.

A number of other hedge funds also recently modified their holdings of the stock. Quantbot Technologies LP acquired a new stake in Enhabit during the fourth quarter worth about $45,000. Group One Trading LLC raised its position in shares of Enhabit by 248.3% in the 4th quarter. Group One Trading LLC now owns 7,746 shares of the company’s stock valued at $60,000 after buying an additional 5,522 shares in the last quarter. Corient Private Wealth LLC bought a new stake in shares of Enhabit during the 4th quarter worth approximately $79,000. Quarry LP boosted its position in shares of Enhabit by 692.6% during the 4th quarter. Quarry LP now owns 10,811 shares of the company’s stock worth $84,000 after acquiring an additional 9,447 shares in the last quarter. Finally, Stoneridge Investment Partners LLC increased its stake in Enhabit by 22.6% in the fourth quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company’s stock valued at $98,000 after acquiring an additional 2,308 shares during the last quarter.

Enhabit Stock Down 1.4%

Shares of NYSE EHAB opened at $10.35 on Tuesday. The company has a market cap of $524.09 million, a price-to-earnings ratio of -4.46 and a beta of 1.61. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit, Inc. has a 12 month low of $6.85 and a 12 month high of $10.79. The stock has a 50-day moving average price of $8.86 and a two-hundred day moving average price of $8.42.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.03. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The business had revenue of $259.90 million during the quarter, compared to analysts’ expectations of $266.11 million. As a group, analysts forecast that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Jefferies Financial Group restated a “buy” rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.